Tuberculosis News and Research

Latest Tuberculosis News and Research

Collaborative study may lead to improved influenza vaccine and vaccines for other respiratory virus infections

A collaborative project between researchers at the Trudeau Institute and their colleagues at St. Jude Children's Research Hospital in Memphis, Tenn., offers new insights that may lead to an improved strategy to protect against the influenza virus and other viruses that infect the respiratory tract.

19 Jan 2011

WHO Director-General opens executive board session with calls for reform

Kicking off a nine-day annual WHO executive board meeting Monday, WHO Director-General Margaret Chan called for the board to consider areas where the agency can redirect resources in a more targeted manner so as to achieve greater outcomes, Reuters reports.

19 Jan 2011

Harbor Biosciences signs development agreements for HE2000, HE3235 and HE3286 with CIPI

Harbor BioSciences, Inc., a leader in the development of a proprietary class of adrenal steroid hormones as novel pharmaceuticals, announced it has licensed the research and development and commercialization rights for three of its products, exclusively in the People's Republic of China and Hong Kong, to China State Institute of Pharmaceutical Industry (CIPI).

18 Jan 2011

Opinions: U.S. HIV funding; Global fund accountability; World food supply

President Barack Obama's Global Health Initiative is "pitting AIDS against other diseases by making investments in new areas of global health contingent on flat funding for efforts to fight the HIV epidemic," HIV/AIDS advocate and Yale College student Gregg Gonsalves writes in a Washington Post opinion piece.

18 Jan 2011

Collaborative Drug Discovery receives additional grant for TB drug research

Collaborative Drug Discovery, Inc. (CDD) today announced that the Bill & Melinda Gates Foundation has extended its previous grant to CDD to create a novel database to spark collaborative efforts to discover more effective drugs against tuberculosis (TB). The TB bacillus infects approximately one third of the world's population and the disease kills over 1.5 million people every year.

14 Jan 2011

IDRI receives Bill and Melinda Gates Foundation multi-million dollar grant to identify new leads in TB

The Infectious Disease Research Institute today announced it has received a multi-million dollar grant from the Bill and Melinda Gates Foundation for "Chemical genomics for the identification of targets and leads in tuberculosis."

14 Jan 2011

Medical aid workers should take pre-travel precautions to prevent disease transmission

Guidance about pre-travel precautions and preventive measures are highlighted in the December 1, 2010 issue of Clinical Infectious Diseases, written by clinicians and researchers at the Uniformed Services University of the Health Sciences and their partners from the University of Texas Health Sciences Center, Naval Medical Research Center and others.

11 Jan 2011

AlertNet features 20 low-cost ideas that could improve health, reduce poverty

AlertNet posed health, technology, water and other experts questions, such as, "[w]hat cheap, low-tech innovations could be used to improve the lives of the poor? Which potentially life-saving ideas have been knocking around for years but still aren't widely practised?"

11 Jan 2011

Lancet World Report examines health risks associated with inaccurate TB tests, WHO's upcoming recommendations

With "scores of commercial serology tests for tuberculosis ... being sold in high-burden countries," the "WHO is due to release a negative policy recommendation - the first of its kind for the organisation" - after several reviews have "indicated poor performance of these tests," Lancet World Report writes in a piece that documents the health risks associated with a growing number of inaccurate TB tests.

10 Jan 2011

DARPA grants million dollar to IDRI to develop single dose influenza vaccine

The Infectious Disease Research Institute today announced it has received a multi-million dollar grant from the Defense Advanced Research Projects Agency, and the Army Research Office, both parts of United States Department of Defense.

7 Jan 2011

FDA awards supplemental approval to support efficacy of ACTEMRA in treating RA

Genentech, Inc., a member of the Roche Group, today announced that the United States Food and Drug Administration has extended the ACTEMRA (tocilizumab, RoACTEMRA in the European Union) label to include inhibition and slowing of structural joint damage, improvement of physical function, and achievement of major clinical response in adult patients with moderately to severely active rheumatoid arthritis, when given in combination with methotrexate.

6 Jan 2011

American Heart Association partners in global effort to prepare for UN non-communicable diseases summit

The American Heart Association is participating in an international effort to prepare for a United Nations (UN) high-level summit next year on non-communicable diseases (NCDs). These diseases — mainly cardiovascular illnesses including stroke, diabetes, cancer and chronic respiratory conditions — were estimated to cause more than 60 percent of deaths worldwide in 2005.

5 Jan 2011

Lancet editorial highlights similarities between current health challenges, those from 1911

"After a century of progress, the issues that medicine must tackle in the coming year aren't that different from the ones that faced doctors at the start of 1911, according to the observations" published Jan. 1 in a Lancet editorial, LiveScience reports (Parry, 12/30).

4 Jan 2011

Immunitor reports positive safety imm01 clinical trial against tuberculosis

Immune Network Ltd., advises that Immunitor has published data from the first half of the 120-patient imm01 clinical trial of its V5 immunomodulator product against tuberculosis, including difficult-to-treat forms of the disease.

30 Dec 2010

Centocor Ortho Biotech files REMICADE sBLA for ulcerative colitis in pediatric patients

Centocor Ortho Biotech Inc. announced today that it has filed a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) requesting the approval of REMICADE® (infliximab) for the treatment of moderately to severely active ulcerative colitis (UC) in pediatric patients who have had an inadequate response to conventional therapy.

29 Dec 2010

Research reaffirms bovine TB's threat to humans, animals, and to international trade

As part of his doctoral research at The Norwegian School of Veterinary Science, Demelash Biffa has carried out extensive field and laboratory work on bovine tuberculosis (TB) in Ethiopia since 2007. The main aims of his study were to investigate risk factors associated with prevalence of the disease and to discover the molecular genetic characteristics of mycobacteria, which cause serious pathologic lesions in cattle. The work has led to the development of a new numeric expression approach known as Spoligotype Evolutionary Index (SEI).

24 Dec 2010

Chinese government should show more leadership on HIV/AIDS, says AHF

In response to news that the most recent round of grants issued by the Global Fund to Fight AIDS, Tuberculosis and Malaria is nearly $1 billion less than just two years ago, AIDS Healthcare Foundation (AHF) today called on nations to give more to help fight HIV/AIDS around the globe.

23 Dec 2010

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for the prevention of anal cancer caused by human papillomavirus (HPV) types 16 and 18 and for the prevention of anal intraepithelial neoplasia (AIN) grades 1, 2 and 3 (anal dysplasias and precancerous lesions) caused by HPV types 6, 11, 16 and 18, in males and females 9 through 26 years of age.

23 Dec 2010

Life expectancy, other health indicators improve in Asia-Pacific, OECD report says

A report from the Organization for Economic Cooperation and Development (OECD) released on Tuesday, found that "Asia-Pacific countries have seen steady gains in key health indicators since 1970, but developing nations there are still far behind standards in the industrialised world," Deutsche Presse-Agentur/M&C reports. OECD looked at "[h]ealth systems for 27 Asia-Pacific economies," according to the news service (12/21).

22 Dec 2010

New CPT code for use with T-SPOT.TB test

Oxford Immunotec, Inc. announces that a new and specific Current Procedural Terminology (CPT®) code has been established by the American Medical Association for use with the T-SPOT®.TB test. The new Category I code, 86481, is described as "Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension." This new code will be effective as of January 1, 2011.

21 Dec 2010

Tuberculosis News and Research

Latest Tuberculosis News and Research

Collaborative study may lead to improved influenza vaccine and vaccines for other respiratory virus infections

WHO Director-General opens executive board session with calls for reform

Harbor Biosciences signs development agreements for HE2000, HE3235 and HE3286 with CIPI

Opinions: U.S. HIV funding; Global fund accountability; World food supply

Collaborative Drug Discovery receives additional grant for TB drug research

IDRI receives Bill and Melinda Gates Foundation multi-million dollar grant to identify new leads in TB

Medical aid workers should take pre-travel precautions to prevent disease transmission

AlertNet features 20 low-cost ideas that could improve health, reduce poverty

Lancet World Report examines health risks associated with inaccurate TB tests, WHO's upcoming recommendations

DARPA grants million dollar to IDRI to develop single dose influenza vaccine

FDA awards supplemental approval to support efficacy of ACTEMRA in treating RA

American Heart Association partners in global effort to prepare for UN non-communicable diseases summit

Lancet editorial highlights similarities between current health challenges, those from 1911

Immunitor reports positive safety imm01 clinical trial against tuberculosis

Centocor Ortho Biotech files REMICADE sBLA for ulcerative colitis in pediatric patients

Research reaffirms bovine TB's threat to humans, animals, and to international trade

Chinese government should show more leadership on HIV/AIDS, says AHF

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

Life expectancy, other health indicators improve in Asia-Pacific, OECD report says

New CPT code for use with T-SPOT.TB test

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in